Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. United Kingdom
  4. London Stock Exchange
  5. ConvaTec Group Plc
  6. Summary
    CTEC   GB00BD3VFW73

CONVATEC GROUP PLC

(CTEC)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed London Stock Exchange
11/30/2021 12/01/2021 12/02/2021 12/03/2021 12/06/2021 Date
193(c) 193.6(c) 191.9(c) 191.25(c) 195.7 Last
5 001 718 6 024 662 2 612 524 3 150 961 3 099 932 Volume
-0.85% +0.31% -0.88% -0.34% +2.33% Change
More quotes
Estimated financial data (e) (USD)
Sales 2021 2 028 M - -
Net income 2021 124 M - -
Net Debt 2021 900 M - -
P/E ratio 2021 42,7x
Yield 2021 2,11%
Sales 2022 2 109 M - -
Net income 2022 160 M - -
Net Debt 2022 758 M - -
P/E ratio 2022 32,4x
Yield 2022 2,24%
Capitalization 5 092 M 5 088 M -
EV / Sales 2021 2,95x
EV / Sales 2022 2,77x
Nbr of Employees 9 914
Free-Float 79,9%
More Financials
Company
ConvaTec Group PLC is a United Kingdom-based medical product and technology company. The Company focuses on therapies for the management of chronic conditions, including products used for advanced chronic and acute wound care, ostomy care, continence and critical care and infusion devices used in the treatment of diabetes and other conditions. It operates across market franchises, such as Advanced Wound Care, which... 
More about the company
Ratings of ConvaTec Group Plc
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
B+
More Ratings
All news about CONVATEC GROUP PLC
11/22CONVATEC : 25 years of AQUACEL 22 November 2021
PU
11/19RLS Global AB secures financing of SEK 20 million
AQ
11/08ConvaTec awarded contract for Advanced Wound Care Products from Vizient, Inc. 08 Novemb..
PU
10/29ConvaTec Updates FY21 Guidance As Q3 Revenue Grows 4%
MT
10/29FTSE Falls as NatWest Drops After Quarterly Results
DJ
10/29Trading update for the three months ended 30 September 2021 29 October 2021
PU
10/29ConvaTec Group Plc Reports Revenue Results for the Third Quarter and Nine Months Ended ..
CI
10/29ConvaTec Group plc Provides Earnings Guidance for the Year 2021
CI
10/29FTSE to Open Lower as Apple, Amazon Hit by Supply Chain Issues
DJ
10/01CONVATEC : Announces Pricing of $500 Million 3.875% Senior Notes due 2029 01 October 2021
PU
10/01CONVATEC : Prices $500 Million Senior Notes Offering
MT
09/30CONVATEC : Announces Offering of $500 Million Senior Notes due 2029 30 September 2021
PU
09/30CONVATEC : Issues $500 Million Of Senior Notes Due 2029
MT
09/30ConvaTec Group Plc Announces Offer of $500 Million Senior Notes Due 2029
CI
09/23VEEVA : Says ConvaTec Picked its Clinical Data Management System for Biomarker Study in Wo..
MT
More news
News in other languages on CONVATEC GROUP PLC
10/29ConvaTec révise ses prévisions pour l'exercice 21 et enregistre une hausse de 4 % de so..
10/29ConvaTec Group plc fournit des prévisions de résultats pour l'année 2021
10/01Le groupe ConvaTec fixe le prix de son offre de billets de premier rang d'une valeur de..
09/30Convatec émet 500 millions de dollars d'obligations de premier rang à échéance 2029
09/12Moody's relève la note de ConvaTec en raison des "progrès significatifs" de la restruct..
More news
Analyst Recommendations on CONVATEC GROUP PLC
More recommendations
Chart CONVATEC GROUP PLC
Duration : Period :
ConvaTec Group Plc Technical Analysis Chart | CTEC | GB00BD3VFW73 | MarketScreener
Technical analysis trends CONVATEC GROUP PLC
Short TermMid-TermLong Term
TrendsBearishBearishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 15
Last Close Price 2,53 $
Average target price 3,37 $
Spread / Average Target 33,3%
EPS Revisions
Managers and Directors
Karim Sani Nasib Bitar Chief Executive Officer & Director
Frank M. Schulkes Chief Financial Officer & Director
John David Gibson McAdam Chairman
Robert Steele EVP-Quality, Clinical & Regulatory Affairs
Donal Balfe Executive Vice President-Global Operations
Sector and Competitors
1st jan.Capi. (M$)
CONVATEC GROUP PLC-3.99%5 088
ABBOTT LABORATORIES18.98%230 355
MEDTRONIC PLC-8.77%143 693
BECTON, DICKINSON AND COMPANY-3.42%69 336
HOYA CORPORATION28.35%59 756
DEXCOM, INC.40.51%50 350